![David Dellamonica](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Dellamonica is Director of Development Affairs for TxCell SA. Prior to joining TxCell in March, 2007, he was Director of Life Sciences for Team Agency and Director of Health Business Development for SQL Ingénierie SA (SQLI, system Biology).
Previously, Mr. Dellamonica worked for Nex&Com health and Polygram Universal.
He received an MBA from the Paris Superior School of Management.
| Unternehmen | Position | Ende |
|---|---|---|
| SQLI | Corporate Officer/Principal | - |
| TXCELL | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
SQLI SA
 SQLI SA Information Technology ServicesTechnology Services Provides information technology solutions | Technology Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
